Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study Naor Bar-Zeev, PhD, Lester Kapanda, MSc, Jacqueline E Tate, PhD, Khuzwayo C Jere, PhD, Prof Miren Iturriza-Gomara, PhD, Prof Osamu Nakagomi, PhD, Charles Mwansambo, FRCPCH, Prof Anthony Costello, FMedSci, Umesh D Parashar, MPH, Prof Robert S Heyderman, PhD, Prof Neil French, PhD, Prof Nigel A Cunliffe, PhD The Lancet Infectious Diseases Volume 15, Issue 4, Pages 422-428 (April 2015) DOI: 10.1016/S1473-3099(14)71060-6 Copyright © 2015 Bar-Zeev, et al. Open Access article distributed under the terms of CC BY Terms and Conditions
Figure 1 Rotavirus gastroenteritis detection by month in Queen Elizabeth Central Hospital, Blantyre (A) Number of rotavirus cases per month. (B) Proportion of stool samples positive for rotavirus. The Lancet Infectious Diseases 2015 15, 422-428DOI: (10.1016/S1473-3099(14)71060-6) Copyright © 2015 Bar-Zeev, et al. Open Access article distributed under the terms of CC BY Terms and Conditions
Figure 2 Rotavirus VP7 (G) genotypes detected by month in children younger than 5 years of age presenting to Queen Elizabeth Central Hospital, Blantyre, from Jan 1, 2012, to June 30, 2014 Graph excludes mixed infection. The Lancet Infectious Diseases 2015 15, 422-428DOI: (10.1016/S1473-3099(14)71060-6) Copyright © 2015 Bar-Zeev, et al. Open Access article distributed under the terms of CC BY Terms and Conditions